Skip to main content
FIREFLY NEUROSCIENCE, INC. logo

FIREFLY NEUROSCIENCE, INC. — Investor Relations & Filings

Ticker · AIFF ISIN · US4566961037 US Professional, scientific and technical activities
Filings indexed 624 across all filing types
Latest filing 2022-12-02 Director's Dealing
Country US United States of America
Listing US AIFF

About FIREFLY NEUROSCIENCE, INC.

https://fireflyneuro.com/

Firefly Neuroscience, Inc. is a medical technology and artificial intelligence company that develops solutions to improve brain health outcomes. The company's flagship product is the FDA-cleared Brain Network Analytics (BNA™) platform, which provides objective, AI-driven assessments for neurological and psychiatric disorders. The BNA™ platform utilizes electroencephalogram (EEG) data, including Event-Related Potentials (ERPs) and spectral analysis, combined with behavioral performance metrics. Using advanced AI, the platform compares a patient's brain activity against an extensive, proprietary, and standardized database of over 17,000 individuals. This process generates a comprehensive, cloud-based report for healthcare professionals, enabling them to make more informed decisions for disease management and personalized treatment plans. The technology serves clinicians and supports CNS drug developers in biomarker discovery and companion diagnostics.

Recent filings

Filing Released Lang Actions
FORM4_BENOIT_221201
Director's Dealing
2022-12-02 English
FORM4_BENOIT_221129
Director's Dealing
2022-11-30 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-11-25 English
FORM4_BECKER_221121
Director's Dealing
2022-11-23 English
FORM4_BENOIT_221121
Director's Dealing
2022-11-23 English
FORM4_DIPAULA_221121
Director's Dealing
2022-11-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.